These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 3020314
1. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding. Kramer HJ, Baecker A, Weiler E, Liddiard C. Klin Wochenschr; 1986 Aug 15; 64(16):760-6. PubMed ID: 3020314 [Abstract] [Full Text] [Related]
2. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine. Clarkson EM, de Wardener HE. Clin Exp Hypertens A; 1985 Aug 15; 7(5-6):673-83. PubMed ID: 2990768 [Abstract] [Full Text] [Related]
3. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct. Kramer HJ, Krampitz G, Bäcker A, Meyer-Lehnert H. Clin Exp Hypertens; 1998 Aug 15; 20(5-6):557-71. PubMed ID: 9682912 [Abstract] [Full Text] [Related]
8. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation. Kramer HJ, Meyer-Lehnert H, Michel H, Predel HG. Am J Hypertens; 1991 Jan 15; 4(1 Pt 1):81-9. PubMed ID: 1848764 [Abstract] [Full Text] [Related]
9. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase. Kramer HJ, Krampitz G, Bäcker A, Michel H, Krampitz G, Meyer-Lehnert H. Am J Hypertens; 1995 Jul 15; 8(7):753-60. PubMed ID: 7546503 [Abstract] [Full Text] [Related]
10. Further biochemical characterization of an Na+ pump inhibitor purified from human urine. Crabos M, Grichois ML, Guicheney P, Wainer IW, Cloix JF. Eur J Biochem; 1987 Jan 02; 162(1):129-35. PubMed ID: 3028785 [Abstract] [Full Text] [Related]
11. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal. Tamura M, Lam TT, Inagami T. Biochemistry; 1988 Jun 14; 27(12):4244-53. PubMed ID: 2844224 [Abstract] [Full Text] [Related]
12. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin. Weiler EW, Gonick HC, Prins BA, Purdy RE, Weber MA. Am J Med Sci; 1994 Jan 14; 307(1):27-35. PubMed ID: 8291503 [Abstract] [Full Text] [Related]
13. Effects of lead and natriuretic hormone on kinetics of sodium-potassium-activated adenosine triphosphatase: possible relevance to hypertension. Weiler E, Khalil-Manesh F, Gonick H. Environ Health Perspect; 1988 Jun 14; 78():113-7. PubMed ID: 2849538 [Abstract] [Full Text] [Related]
14. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine. Levine BH, Murray ED, Bigornia AE, DeWind SA, Wechter WJ. J Cardiovasc Pharmacol; 1993 Jun 14; 22 Suppl 2():S63-8. PubMed ID: 7508032 [Abstract] [Full Text] [Related]
18. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation. Kramer HJ. Klin Wochenschr; 1981 Nov 16; 59(22):1225-30. PubMed ID: 6273645 [Abstract] [Full Text] [Related]